The Patent Finder

Armo Biosciences, Inc.

10 patents currently held · Updated Nov 17, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Apr 2034
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Nov 21, 2026
    The maintenance fee for Methods of lowering serum cholesterol (US 10,293,043) comes due Nov 21, 2026. Unpaid by May 21, 2027, it lapses early.
  • 1 fee due Jan 23, 2027
    The maintenance fee for Methods of using interleukin-10 for treating solid tumors (US 10,357,545) comes due Jan 23, 2027. Unpaid by Jul 23, 2027, it lapses early.
  • 1 fee due Mar 3, 2027
    The maintenance fee for Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers (US 10,398,761) comes due Mar 3, 2027. Unpaid by Sep 3, 2027, it lapses early.
  • 1 fee due Oct 14, 2027
    The maintenance fee for Method of treating cancer with IL-10 and antibodies that induce ADCC (US 10,618,970) comes due Oct 14, 2027. Unpaid by Apr 14, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 10 of 10

PatentTitleStatus Expires Confidence
US 9,943,568Methods of using pegylated interleukin-10 for treating cancer
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,357,545Methods of using interleukin-10 for treating solid tumors
In force
 · From the USPTO record
In forceFrom the USPTO record
US 9,823,255Method for assessing protein identity and stability
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,209,261Method for assessing protein identity and stability
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,293,043Methods of lowering serum cholesterol
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,143,726Methods of using interleukin-10 for treating diseases and disorders
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,653,751Methods of treating cancer metastasis by using interleukin-10
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,618,970Method of treating cancer with IL-10 and antibodies that induce ADCC
In force
 · From the USPTO record
In forceFrom the USPTO record
US 10,195,274Method of Modulating a Chimeric Antigen Receptor T Cell Immune Response by Administering IL-10
In force
 · High confidence
In forceHigh confidence
US 10,398,761Methods of using combinations of PEG-IL-10 and IL-15 for treating cancers
In force
 · From the USPTO record
In forceFrom the USPTO record
Also on record, not counted in the 10: 2 patents in force now held by others · 3 lapsed for an unpaid fee · 1 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 abandoned · 9 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited